Beyond CGRP: the calcitonin peptide family as targets for migraine and pain

Calcitonin gene-related peptide (CGRP) system has emerged as a key pharmacological target for the treatment of migraine. This review discusses the localisation of the calcitonin family in peripheral pain pathways and discusses how they may contribute to migraine and pain.

British Journal of Clinical Pharmacology